Thrombocytopenia in preeclampsia: associated abnormalities and management principles.
Severe thrombocytopenia, abnormal liver function, and renal dysfunction may occur as manifestations of preeclampsia. Failure to recognize that this cluster of abnormalities represents a form of preeclampsia may result in erroneous initial diagnoses. Management of 13 such patients has shown a direct correlation between the degree of thrombocytopenia and the measures of liver dysfunction. Platelet counts and liver functions improved prior to delivery in five patients treated with corticosteroids. Management should be directed toward investigation and correction of deranged physiology and appropriate monitoring of maternal-feto-placental status. Early delivery is indicated in patients with progressive thrombocytopenia and in those with evidence of fetal maturity or distress. Provided that the disease process remains stable, consideration should be given in cases of fetal immaturity, to the use of betamethasone therapy. The occurrence of severe thrombocytopenia in 20% of neonates should be a consideration in selecting the mode of delivery.
D000328:Adult; D001623:Betamethasone / Q000627:therapeutic use; D001724:Birth Weight; D036861:Delivery, Obstetric; D005260:Female; D005312:Fetal Blood / Q000032:analysis; D006801:Humans; D007231:Infant, Newborn; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008278:Magnesium Sulfate / Q000627:therapeutic use; D008297:Male; D010976:Platelet Count; D011225:Pre-Eclampsia / Q000150:complications* / Q000175:diagnosis; D011247:Pregnancy; D013921:Thrombocytopenia / Q000209:etiology*
D008278:Magnesium Sulfate; D001623:Betamethasone